These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3923410)

  • 1. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
    Nutr Rev; 1985 Apr; 43(4):103-5. PubMed ID: 3923410
    [No Abstract]   [Full Text] [Related]  

  • 2. Deferoxamine and aluminum removal.
    Swartz RD
    Am J Kidney Dis; 1985 Nov; 6(5):358-64. PubMed ID: 3904429
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure.
    Malluche HH; Smith AJ; Abreo K; Faugere MC
    N Engl J Med; 1984 Jul; 311(3):140-4. PubMed ID: 6377067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminum and iron deposition in dialysis patients].
    Kurihara S; Marumo F
    Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC; Arnala IO; Ritz E; Malluche HH
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dialysis bone disease associated with other factors].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():789-95. PubMed ID: 1578768
    [No Abstract]   [Full Text] [Related]  

  • 8. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB; Hood SA; Brown P; Cordy PE
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 10. Persisting aluminium-related bone disease after cadaveric renal transplantation.
    Nicholas JC; Dawes PT; Davies SJ; Freemont AJ
    Nephrol Dial Transplant; 1999 Jan; 14(1):202-4. PubMed ID: 10052510
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
    Klein GL; Snodgrass WR; Griffin MP; Miller NL; Alfrey AC
    J Pediatr Gastroenterol Nutr; 1989 Oct; 9(3):400-3. PubMed ID: 2515268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone histologic response to deferoxamine in aluminum-related bone disease.
    Andress DL; Nebeker HG; Ott SM; Endres DB; Alfrey AC; Slatopolsky EA; Coburn JW; Sherrard DJ
    Kidney Int; 1987 Jun; 31(6):1344-50. PubMed ID: 2441107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of aluminum in aluminum osteodystrophy with liver disease.
    Williams JW; Vera SR; Peters TG; Luther RW; Bhattacharya S; Spears H; Graham A; Pitcock JA; Crawford AJ; Palmieri GM
    Ann Intern Med; 1986 Jun; 104(6):782-5. PubMed ID: 3706930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Contrib Nephrol; 1988; 64():134-43. PubMed ID: 3180820
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Feb; 114(7):253-7. PubMed ID: 2917487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R; Dombrouski J; Burnatowska-Hledin M; Mayor G
    Am J Kidney Dis; 1987 Mar; 9(3):217-23. PubMed ID: 3826071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.
    Mazzaferro S; Coen G; Ballanti P; Costantini S; Bondatti F; Giordano R; Manni M; Pasquali M; Perruzza I; Sardella D
    Nephron; 1992; 61(2):151-7. PubMed ID: 1630538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum as a factor in the bone disease of long-term parenteral nutrition.
    Klein GL; Ott SM; Alfrey AC; Sherrard DJ; Hazlet TK; Miller NL; Maloney NA; Berquist WE; Ament ME; Coburn JW
    Trans Assoc Am Physicians; 1982; 95():155-64. PubMed ID: 6820740
    [No Abstract]   [Full Text] [Related]  

  • 19. High bone turnover associated with an aluminum-induced impairment of bone mineralization.
    Charhon SA; Chavassieux PM; Chapuy MC; Traeger J; Meunier PJ
    Bone; 1986; 7(5):319-24. PubMed ID: 3790372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum and renal osteodystrophy.
    Nebeker HG; Coburn JW
    Annu Rev Med; 1986; 37():79-95. PubMed ID: 3085581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.